Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Vining

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
World Journal of Radiology|May 15, 2013
Virtual colonoscopy: Utility, impact and overviewDhakshina Ganeshan, Khaled M Elsayes, David Vining
JCO Precision Oncology|September 24, 2019
Prolonged Partial Response to Bevacizumab and Valproic Acid in a Patient With GlioblastomaElena Fountzilas, Gary Palmer, David Vining, et al.
Therapeutic Advances in Medical Oncology|May 17, 2021
Prolonged response to treatment based on cell-free DNA analysis and molecular profiling in three patients with metastatic cancer: a case seriesMohammad Faraz Naqvi, Henry Hiep Vo, David Vining, et al.
Journal of General Internal Medicine|October 30, 2008
Extracolonic findings at virtual colonoscopy: an important consideration in asymptomatic colorectal cancer screeningJames R Kimberly, Kim C Phillips, Pete Santago, et al.
Molecular Cancer Therapeutics|January 12, 2011
Effects of patupilone on the pharmacokinetics and pharmacodynamics of warfarin in patients with advanced malignancies: a phase I clinical trialApostolia-Maria Tsimberidou, Chris H M Takimoto, Stacy Moulder, et al.
Cancers|March 10, 2022
Ipilimumab, Pembrolizumab, or Nivolumab in Combination with BBI608 in Patients with Advanced Cancers Treated at MD Anderson Cancer CenterHenry Hiep Vo, Carrie Cartwright, I-Wen Song, et al.
The Oncologist|April 27, 2023
Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated CancersVan K Morris, Amir Jazaeri, Shannon N Westin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2021
Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid TumorsApostolia M Tsimberidou, Philip A Beer, Carrie A Cartwright, et al.
Journal for Immunotherapy of Cancer|February 3, 2024
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinomaRodabe Amaria, Anne Knisely, David Vining, et al.
Cancer|November 27, 2023
Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancerEmily M Hinchcliff, Anne Knisely, Naomi Adjei, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
World Journal of Radiology|May 15, 2013
Virtual colonoscopy: Utility, impact and overviewDhakshina Ganeshan, Khaled M Elsayes, David Vining
JCO Precision Oncology|September 24, 2019
Prolonged Partial Response to Bevacizumab and Valproic Acid in a Patient With GlioblastomaElena Fountzilas, Gary Palmer, David Vining, et al.
Therapeutic Advances in Medical Oncology|May 17, 2021
Prolonged response to treatment based on cell-free DNA analysis and molecular profiling in three patients with metastatic cancer: a case seriesMohammad Faraz Naqvi, Henry Hiep Vo, David Vining, et al.
Journal of General Internal Medicine|October 30, 2008
Extracolonic findings at virtual colonoscopy: an important consideration in asymptomatic colorectal cancer screeningJames R Kimberly, Kim C Phillips, Pete Santago, et al.
Molecular Cancer Therapeutics|January 12, 2011
Effects of patupilone on the pharmacokinetics and pharmacodynamics of warfarin in patients with advanced malignancies: a phase I clinical trialApostolia-Maria Tsimberidou, Chris H M Takimoto, Stacy Moulder, et al.
Cancers|March 10, 2022
Ipilimumab, Pembrolizumab, or Nivolumab in Combination with BBI608 in Patients with Advanced Cancers Treated at MD Anderson Cancer CenterHenry Hiep Vo, Carrie Cartwright, I-Wen Song, et al.
The Oncologist|April 27, 2023
Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated CancersVan K Morris, Amir Jazaeri, Shannon N Westin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2021
Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid TumorsApostolia M Tsimberidou, Philip A Beer, Carrie A Cartwright, et al.
Journal for Immunotherapy of Cancer|February 3, 2024
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinomaRodabe Amaria, Anne Knisely, David Vining, et al.
Cancer|November 27, 2023
Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancerEmily M Hinchcliff, Anne Knisely, Naomi Adjei, et al.
Pageof 2